Clinical Trials
149
Active:13
Completed:51
Trial Phases
6 Phases
Early Phase 1:1
Phase 1:11
Phase 2:36
+3 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (119 trials with phase data)• Click on a phase to view related trials
Not Applicable
60 (50.4%)Phase 2
36 (30.3%)Phase 1
11 (9.2%)Phase 3
10 (8.4%)Early Phase 1
1 (0.8%)Phase 4
1 (0.8%)Radiotherapy 12Gy in 6 Fractions For Orbital Lymphoma
Not Applicable
Not yet recruiting
- Conditions
- Orbital Lymphoma
- First Posted Date
- 2025-10-07
- Last Posted Date
- 2025-10-07
- Lead Sponsor
- British Columbia Cancer Agency
- Target Recruit Count
- 36
- Registration Number
- NCT07210749
- Locations
- 🇨🇦
BC Cancer Vancouver, Vancouver, British Columbia, Canada
SABR PRIMER - Evaluating Stereotactic Ablative Radiotherapy for Primary and Regional Breast Tumors
Not Applicable
Not yet recruiting
- Conditions
- Breast CancerMetastases
- First Posted Date
- 2025-04-22
- Last Posted Date
- 2025-04-24
- Lead Sponsor
- British Columbia Cancer Agency
- Target Recruit Count
- 40
- Registration Number
- NCT06937281
- Locations
- 🇨🇦
BC Cancer - Vancouver, Vancouver, British Columbia, Canada
DOTATATE PET for Meningioma Radiation Planning
Not Applicable
Not yet recruiting
- Conditions
- Meningioma
- First Posted Date
- 2025-04-22
- Last Posted Date
- 2025-04-22
- Lead Sponsor
- British Columbia Cancer Agency
- Target Recruit Count
- 36
- Registration Number
- NCT06937268
- Locations
- 🇨🇦
BC Cancer - Vancouver, Vancouver, British Columbia, Canada
Stereotactic Radiotherapy Versus Palliative Conventional Radiotherapy for Oligoprogressive Metastatic Cancers
Not Applicable
Not yet recruiting
- Conditions
- OligoprogressionOligometastatic DiseaseOligoProgressive Metastatic Disease
- First Posted Date
- 2025-04-09
- Last Posted Date
- 2025-04-09
- Lead Sponsor
- British Columbia Cancer Agency
- Target Recruit Count
- 194
- Registration Number
- NCT06918951
- Locations
- 🇨🇦
BC Cancer - Surrey, Surrey, British Columbia, Canada
Single vs Hypofractionated Irradiation For Timely Access to Partial Breast Radiotherapy
Not Applicable
Not yet recruiting
- Conditions
- Breast Cancer Early Stage Breast Cancer (Stage 1-3)
- First Posted Date
- 2025-03-20
- Last Posted Date
- 2025-09-19
- Lead Sponsor
- British Columbia Cancer Agency
- Target Recruit Count
- 60
- Registration Number
- NCT06885671
- Prev
- 1
- 2
- 3
- 4
- 5
- 30
- Next
News
No news found